The Ultimate Guide to GLP-1, GIP & Next-Generation Weight Loss Drugs (2026)

Introduction: The New Era of Fat Loss

The weight loss industry has undergone a massive transformation with the rise of GLP-1 receptor agonists and next-generation incretin-based therapies. What was once a slow, frustrating process is now being revolutionized by compounds capable of producing 15–30% total body weight loss—numbers previously only achievable with bariatric surgery.

At the forefront of this revolution are drugs like Tirzepatide, Semaglutide, and emerging powerhouses like Retatrutide and CagriSema.

This guide breaks down every major GLP-based compound, ranks them based on real-world effectiveness, and shows you what’s coming next—so you can stay ahead of the curve.

Browse clinical-grade options

Understanding GLP-1, GIP & Glucagon (Core Mechanisms)

Before ranking the drugs, you need to understand how they work.

GLP-1 (Glucagon-Like Peptide-1)

  • Reduces appetite
  • Slows gastric emptying
  • Improves insulin sensitivity

GIP (Glucose-Dependent Insulinotropic Polypeptide)

  • Enhances insulin response
  • May improve fat metabolism

Glucagon Receptor Activation

  • Increases energy expenditure
  • Promotes fat burning

👉 The more pathways activated, the more powerful the fat loss effect.

🏆 GLP Drug Rankings (2026 Authority List)

🥇 1. Retatrutide — The Triple Agonist King

Mechanism:
  • GLP-1 + GIP + Glucagon
Results:
  • Up to 24–30% weight loss
Why It Dominates:

Retatrutide is the first compound to fully combine appetite suppression AND metabolic acceleration.

Unlike older drugs that only make you eat less, this one also makes your body burn more fat at rest.

Pros:
  • Highest fat loss ever recorded
  • Increased energy expenditure
  • Visceral fat reduction
Cons:
  • Not FDA approved yet
  • Strong side effects at high doses

👉 Verdict: Future #1 drug in the world

View

🥈 2. Tirzepatide — Current Gold Standard

Mechanism:
  • GLP-1 + GIP
Results:
  • 15–25% weight loss
Why It Works:

Tirzepatide combines appetite suppression with improved metabolic signaling, making it significantly more effective than semaglutide.

Pros:
  • Widely available
  • Strong appetite control
  • Excellent insulin sensitivity
Cons:
  • Nausea during titration
  • Can suppress appetite too much

👉 Verdict: Best option available TODAY

View

🥉 3. CagriSema — Appetite Suppression Monster

Mechanism:
  • Semaglutide + Cagrilintide (Amylin analog)
Results:
  • ~20–25% weight loss
Why It’s Unique:

This stack targets satiety signaling from multiple angles, making hunger almost disappear.

Pros:
  • Highest fat loss ever recorded
  • Increased energy expenditure
  • Visceral fat reduction
Cons:
  • Less metabolic boost vs Retatrutide
  • Still in trials

👉 Verdict: Likely top 3 globally

View

🏅 4. Survodutide — The Liver Fat Specialist

Mechanism:
  • GLP-1 + Glucagon
Results:
  • Strong fat loss + NAFLD improvement
Why It Matters:

This drug excels in reducing liver fat, making it ideal for metabolic disease patients.

👉 Verdict: Best niche metabolic drug

View

🏅 5. Semaglutide — The Pioneer

Mechanism:
  • GLP-1 only
Results:
  • 10–15% weight loss
Pros:
  • Proven track record
  • Widely prescribed
Cons:
  • Outperformed by newer drugs
    👉 Verdict: Reliable but outdated
View

🏅 6. Mazdutide — The Underrated Contender

Mechanism:
  • GLP-1 + Glucagon
Notes:
  • Strong fat metabolism effects
  • Limited global availability
View

🏅 7. Liraglutide — The Old Guard

Mechanism:
  • GLP-1
Results:
  • 5–8% weight loss
Cons:
  • Daily injections
  • Lower efficacy

🔬 Emerging & Future Drugs

This drug excels in reducing liver fat, making it ideal for metabolic disease patients.

🔹 Orforglipron (Oral GLP-1)

  • First true GLP-1 pill
  • Massive potential for adoption

🔹 VK2735 (GLP-1 + GIP)

  • Early results rival tirzepatide
  • Likely major competitor
RankDrugMechanismWeight LossCategory
🥇 #1RetatrutideGLP-1 + GIP + Glucagon24–30%Elite
🥈 #2TirzepatideGLP-1 + GIP15–25%Gold Standard
🥉 #3CagriSemaGLP-1 + Amylin20–25%High Potency
🏅 #4SurvodutideGLP-1 + GlucagonHighMetabolic
🏅 #5SemaglutideGLP-110–15%Proven
🏅 #6MazdutideGLP-1 + GlucagonModerateEmerging
🏅 #7LiraglutideGLP-15–8%Legacy

🧠 Strategy: Which One Should YOU Choose?

Maximum Fat Loss:

👉 Tirzepatide (now) → Retatrutide (future)

🍽 Appetite Control:

👉 CagriSema

🩺 Metabolic Health:

👉 Survodutide

FAQs

Still have questions? We’re here to help!

Contact Us
What is the strongest GLP-1 drug?

Retatrutide

Is Tirzepatide better than Semaglutide?

Yes — significantly more effective

What will replace Ozempic?

Tirzepatide → Retatrutide

Shop GLP-1 Research Peptides

Veteran-owned, US-based supplier. Third-party lab-tested with COAs and same-day US shipping. For laboratory research use only — not for human or veterinary consumption.

Shop research-grade GLP-1 peptides — third-party tested with COA →

For laboratory and research use only. This article summarizes published scientific literature for informational purposes. It is not intended for human or veterinary use, and nothing here is medical advice or a dosing recommendation.

Research References

  1. Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205–216. Link
  2. Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384(11):989–1002. PubMed
  3. Jastreboff AM, et al. Triple–hormone-receptor agonist retatrutide for obesity — a phase 2 trial. N Engl J Med. 2023;389(6):514–526. PubMed
  4. Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a phase 2 trial. Lancet Diabetes Endocrinol. 2024. PubMed

Written by Jay Cipollone, Founder & Research Lead, MyGLP1Store — a veteran-owned, U.S.-based research-peptide supplier with third-party lab testing and published certificates of analysis (COAs).